Testing effectiveness (Phase 2)WithdrawnNCT03758729
What this trial is testing
Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma.
Who this might be right for
Melanoma
Samsung Medical Center